Skip to main content

Morningside — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

113
Companies
$2.0B
Total invested
$25.2M
Avg. check
34
Industries
Health Care 16Biotechnology 12Medical 8Medical Device 7Therapeutics 7Pharmaceutical 4+28 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 113
Otolith Labs
September 2022

Otolith Labs develops a therapeutic device for the treatment of vertigo.

Medical · Washington$20.0M Series A
Semios
September 2021

Semios is an all-in-one crop management platform for tree fruit, nuts, and vines.

Agriculture · Vancouver$100.0M Private Equity
ZielBio
September 2022

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets.

Biotechnology · Charlottesville$7.5M Venture - Series Unknown
Elysium
September 2021

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.

Health Care · New YorkSeries C
PhoreMost
September 2024

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Biopharma · Cambridge$12.0M Series B
Endolytix
August 2024

Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.

Biotechnology · Beverly$5.0M Debt Financing
Cyted
August 2025

Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.

Artificial Intelligence (AI) · Cambridge$44.0M Series B
Prospective Research
August 2022

Prospective Research is creating feed incorporated preventative disease management solutions.

Biotechnology · BeverlyConvertible Note
Aural Analytics
July 2022

We build applications that use speech to detect subtle changes in brain health.

Artificial Intelligence (AI) · Scottsdale$1.4M Grant
Linus Health
July 2021

Linus Health is a digital health company focused on improving mental health and brain health by using screening technology.

Health Care · Waltham$55.0M Series B
Yoga Llama
July 2023

Yoga Llama is an application for cell phones, making its usage easier for the customer.

Fitness · Sofia$1.1M Seed
Fount Bio
July 2021

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Beauty · Cambridge$8.2M Series A
VaxEquity
June 2023

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

Biotechnology · Cambridge$870K Grant
Halo
June 2025

Halo smart glasses feature an AI assistant that remembers, answers, and guides in real time—like a supercharged extension of the mind.

Artificial Intelligence (AI) · San Francisco$1.0M Pre-Seed
Ampa Health
May 2026

Ampa Health is a health technology business developing scalable brain stimulation technologies to treat depression, anxiety, and addiction.

Biotechnology · San DiegoSeed
Suvera
May 2025

Support service for effective virtual long-term care

Apps · LondonNon-equity Assistance
Apnimed
April 2026

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Health Care · Cambridge$50.0M Debt Financing
Cydar Medical
April 2025

Cydar Medical has developed computer vision software that produces real-time automated 3D Maps during X-ray guided procedures.

Artificial Intelligence (AI) · CambridgeNon-equity Assistance
Breezeway
March 2026

Breezeway is a property care and services platform designed to reduce the headaches of property management.

Internet · BostonPrivate Equity
Medrhythms
March 2026

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Biotechnology · Boston$3.3M Series Unknown
Vesigen Therapeutics
March 2023

Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.

Biotechnology · CambridgeGrant
ASLAN Pharmaceuticals
March 2024

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Biotechnology · Singapore$5.0M Post-IPO Equity
Adiso Therapeutics
March 2022

Adiso Therapeutics develops medications to treat inflammatory diseases.

Biotechnology · Concord$60.0M Series A
LumiraDx
February 2023

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

Health Care · LondonPost-IPO Equity

Where Morningside invests

Health Care16
Biotechnology12
Medical8
Medical Device7
Therapeutics7
Pharmaceutical4

About Morningside's portfolio

How many companies has Morningside invested in?

Morningside has invested in 113 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Morningside invest in?

Morningside's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Therapeutics. The firm invests across 34 different industry categories.

What is Morningside's largest investment?

Among tracked funding rounds, Semios received $100.0M in a Private Equity round. Morningside's total known invested capital is $2.0B.

What is the average investment size for Morningside?

Morningside's average investment size is $25.2M across its portfolio of 113 companies.

What are Morningside's most recent investments?

Recent Morningside portfolio additions include Otolith Labs, Semios, ZielBio, Elysium, PhoreMost. These companies were founded in 2020 or later.

Reach the founders behind these 113 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →